Overweight or Obesity Clinical Trials

44 recruitingLast updated: July 17, 2026

There are 44 actively recruiting overweight or obesity clinical trials across 23 countries. Studies span Not Applicable, Phase 1, Phase 3, Phase 2, Phase 4. Top locations include Phoenix, Arizona, United States, San Antonio, Texas, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Overweight or Obesity Trials at a Glance

44 actively recruiting trials for overweight or obesity are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 15 trials, with the heaviest enrollment activity in Phoenix, San Antonio, and Chicago. Lead sponsors running overweight or obesity studies include Eli Lilly and Company, BrightGene Bio-Medical Technology Co., Ltd., and Fujian Shengdi Pharmaceutical Co., Ltd..

Browse overweight or obesity trials by phase

Treatments under study

About Overweight or Obesity Clinical Trials

Looking for clinical trials for Overweight or Obesity? There are currently 41 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Overweight or Obesity trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Overweight or Obesity clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 44 trials

Recruiting
Not Applicable

Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain

Overweight or Obesity
ORI Community and Evaluation Services120 enrolled1 locationNCT07708064
Recruiting
Not Applicable

Better Lifestyle Counseling for African American Women During Pregnancy

ExercisePregnancy ComplicationsStress, Psychological+9 more
University of Illinois at Chicago150 enrolled2 locationsNCT05234125
Recruiting
Phase 2

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

ObesityBody WeightOverweight+5 more
Pfizer872 enrolled65 locationsNCT07575932
Recruiting
Phase 1

A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or Overweight

Healthy VolunteersOverweight or Obesity
Hoffmann-La Roche30 enrolled2 locationsNCT07499050
Recruiting
Phase 3

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

OsteoarthritisOverweight or Obesity
Eli Lilly and Company900 enrolled161 locationsNCT07353931
Recruiting
Phase 1

Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

Overweight or Obesity
Regeneron Pharmaceuticals90 enrolled1 locationNCT07594093
Recruiting
Phase 2

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

ObesityOverweightOverweight and Obesity+2 more
Memorial Sloan Kettering Cancer Center1,785 enrolled1 locationNCT05770570
Recruiting
Phase 2

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

Overweight or Obesity and Elevated Liver Fat
Amgen180 enrolled23 locationsNCT07441252
Recruiting
Not Applicable

Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life

Diabetes Type 2Overweight or Obesity
Yale University20 enrolled1 locationNCT07376655
Recruiting
Phase 4

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Psoriatic ArthritisOverweight or Obesity
Eli Lilly and Company200 enrolled55 locationsNCT06864026
Recruiting
Phase 3

Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity

Hypertension With Overweight or Obesity
Shandong Suncadia Medicine Co., Ltd.648 enrolled2 locationsNCT07528027
Recruiting
Phase 4

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

PsoriasisOverweight or Obesity
Eli Lilly and Company200 enrolled40 locationsNCT06857942
Recruiting
Not Applicable

Acute Impact of Whey Protein-enriched Milk Fat Globule Membrane Supplementation on Postprandial Markers of Heart and Brain Health

Cardiovascular DiseasesCardiometabolic Risk FactorsCognition+2 more
Loughborough University16 enrolled1 locationNCT06953232
Recruiting
Not Applicable

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

Peripheral Artery DiseaseOverweight or Obesity
Northwestern University212 enrolled7 locationsNCT04228978
Recruiting
Phase 2

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US

Overweight or Obesity
Regeneron Pharmaceuticals120 enrolled3 locationsNCT07431086
Recruiting
Phase 1

A Study of LY4064912 in Healthy Participants and With Overweight or Obesity

HealthyOverweight or Obesity
Eli Lilly and Company144 enrolled3 locationsNCT07152002
Recruiting
Phase 3

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

HypertensionOverweight or Obesity
Eli Lilly and Company487 enrolled99 locationsNCT06948435
Recruiting
Phase 1

A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity

Part A: Healthy Part B: Overweight or Obesity
Innovent Biologics Technology Limited (Shanghai R&D Center)104 enrolled1 locationNCT07160400
Recruiting
Phase 1

The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity

Overweight or Obesity
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.66 enrolled1 locationNCT06830343
Recruiting
Phase 3

Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss

Overweight or Obesity
Gan & Lee Pharmaceuticals.500 enrolled2 locationsNCT07292441